DEPARTMENT OF CORRECTIONS

1993 ◽  
Vol 14 (4) ◽  
pp. 154-154
Keyword(s):  
American Academy ◽  
Disease Control ◽  
Medical Record ◽  
Meningococcal Disease ◽  
Index Case ◽  
Nasal Carriage ◽  
Index Patient ◽  
American Academy Of Pediatrics ◽  
Record Review ◽  
Middle Column

In the Addendum on page 18 of the January 1993 issue, the page reference should be 354, not 394. In the Medical Record Review on page 67 of the February 1993 issue, the reference to the sample form in the last paragraph of the middle column should have noted that the form was on page 69. Two abstracts regarding rifampin prophylaxis (September 1992, page 354 and October 1992, page 370) differ about whether the index patient should receive rifampin treatment. Dr. Shelov responds: It was stated in the October abstract that the index case of meningococcal disease should receive rifampin prophylaxis, but this is not the recommendation of the REDBOOK Committee of the American Academy of Pediatrics. Rather, this opinion is the consensus of other experts, including those from the Centers for Disease Control. Many children who have meningococcal disease now are treated with ceftriaxone. Because this antibiotic eradicates nasal carriage of the bacteria, rifampin use is not justified for the index case treated with ceftriaxone. I hope this clarifies further the directions for rifampin prophylaxis in meningococal disease.

It Doesn't Work!

PEDIATRICS ◽  
1978 ◽  
Vol 62 (1) ◽  
pp. 128-128
Author(s):  
Hugh C. Thompson
Keyword(s):  
Health Care ◽  
Child Health ◽  
American Academy ◽  
Medical Record ◽  
Central Office ◽  
Health Record ◽  
Child Health Care ◽  
American Academy Of Pediatrics ◽  
The Family

In the April 1977 issue of Pediatrics (59:636, 1977), Dr. Cunningham recommends that the patient's medical record be given to the family to keep. He urges that the Committee on Standards of Child Health Care consider this subject. For at least 20 years the American Academy of Pediatrics has published for this very purpose, a "Child Health Record." This is publication HE-4 of the Academy and was last revised in 1968. The central office of the Academy tells me that, at the present time, between 50,000 and 100,000 of these are sold annually to physicians for the distribution that Dr. Cunningham recommends.

Tuberculin Testing in the Pediatric Office and Clinic

PEDIATRICS ◽  
1979 ◽  
Vol 64 (6) ◽  
pp. 965-966
Author(s):  
Edwin L. Kendig
Keyword(s):  
American Academy ◽  
Disease Control ◽  
School Children ◽  
Tuberculin Test ◽  
Pediatric Clinic ◽  
American Academy Of Pediatrics ◽  
Tuberculin Testing ◽  
The Difference ◽  
Low Rate

Another article in this issue of Pediatrics, "Assessment of Tuberculin Screening in an Urban Pediatric Clinic," (p 856) again focuses attention on a weighty question: Is routine use of the tuberculin test important? The authors have pointed out the difference in philosophy of the Center for Disease Control, and the American Academy of Pediatrics. The Center for Disease Control recommends that routine tuberculin testing for school children and other similar programs be abandoned if the yield of positive tuberculin reactions is less than 1%1; this recommendation is based on the assumption that discovery of cases at this low rate will not have epidemiologic impact (italics added).

Health Supervision Visits: Should the Immunization Schedule Drive the System?

PEDIATRICS ◽  
1987 ◽  
Vol 79 (4) ◽  
pp. 581-582
Author(s):  
ROBERT J. HAGGERTY
Keyword(s):  
American Academy ◽  
Disease Control ◽  
Immunization Schedule ◽  
Health Supervision ◽  
American Academy Of Pediatrics ◽  
Centers For Disease Control ◽  
Well Child Visit ◽  
Child Visit

The Centers for Disease Control (CDC) recently recommended that the vaccines usually given at the 15- and 18-month visits could be given simultaneously at 15 months, thereby omitting the 18-month well-child visit. There is little doubt that measles-mumps-rubella (MMR) immunization, now recommended by the American Academy of Pediatrics to be given at 15 months of age, and the diphtheria-tetanus-pertussis (DTP) and oral polio booster immunizations, now recommended to be given at 18 months of age, could be given together with no problem at 15 months. But this is not a good enough reason to abandon the 18-month well-child visit. Although I will not argue that we have solid evidence for the effectiveness of any well-child procedures other than immunizations, I believe that the 18-month visit is one of the more important ones and should not be discontinued for all children.

Prophylaxis and Treatment of Neonatal Gonococcal Infections

PEDIATRICS ◽  
1980 ◽  
Vol 65 (5) ◽  
pp. 1047-1048
Author(s):  
Sydney Segal ◽  
Walter B. Anyan ◽  
Reba M. Hill ◽  
Ralph E. Kauffman ◽  
Howard Mofenson ◽  
...  
Keyword(s):  
American Academy ◽  
Disease Control ◽  
Silver Nitrate ◽  
Nitrate Solution ◽  
Newborn Infants ◽  
Silver Nitrate Solution ◽  
Gonococcal Infection ◽  
Ophthalmic Ointment ◽  
American Academy Of Pediatrics ◽  
Primary Agent

The Center for Disease Control (CDC), after consultation with a panel of experts, has revised its recommendations for prevention of gonococcal ophthalmia neonatorum. These recommendations now state, "ophthalmic ointment or drops containing tetracycline or erythromycin or a 1% silver nitrate solution" are effective and acceptable.1-3 This is a change from previous recommendations which highlighted silver nitrate as the primary agent for prophylaxis.4 The American Academy of Pediatrics' committees support these recommendations. The prevalence of largely asymptomatic genital gonococcal infection in pregnant women and the occurrence of gonococcal ophthalmia in untreated infants (estimated at 28%)5 born to infected women indicate the need for continued prophylaxis for all newborn infants.

scholarly journals COVID-19 vaccination for pregnant women: strategies for enhanced coverage

2021 ◽  
Vol 33 (3) ◽  
pp. 539-540
Author(s):  
Jennifer Britto John ◽  
Vinoth Gnana Chellaiyan Devanbu ◽  
Vijayalakshmi Kandaswamy
Keyword(s):  
American Academy ◽  
Disease Control ◽  
Pregnant Women ◽  
Advisory Group ◽  
Inactivated Vaccine ◽  
American Academy Of Pediatrics ◽  
Technical Advisory Group ◽  
Control And Prevention ◽  
The Government ◽  
Restricted Use

Following the recommendations from the National Technical Advisory Group (NTAG) on Immunization, the Government of India approved three vaccines – an inactivated vaccine, Covaxin and two non-replicating vector-based vaccines, Covishield and Sputnik V for restricted use in an emergency for pregnant women.(1)The late approval of vaccination of pregnant women was due to a lack of evidence, because pregnant women were excluded from previous COVID vaccination trials. The restricted use of this vaccine recommended by NTAG also complies with the regulations of the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics. (2-4)

The Recommended Childhood Immunization Schedule of the United States

PEDIATRICS ◽  
1995 ◽  
Vol 95 (1) ◽  
pp. 135-137 ◽  
Author(s):  
Caroline Breese Hall
Keyword(s):  
United States ◽  
Infectious Diseases ◽  
American Academy ◽  
Disease Control ◽  
Advisory Committee ◽  
The United States ◽  
Routine Immunization ◽  
Immunization Schedule ◽  
Childhood Immunization ◽  
American Academy Of Pediatrics

The complexity of our current schedule for routine immunization of children is expanding and experienced by both physician and parent. Over nearly two decades in the 1970s and 1980s only one new vaccine was added to the routine immunization for children. However, in the last few years since 1989, the schedule routinely recommended for children has been augmented by eight to ten new doses or vaccines. The confusion has been compounded by differences in the schedules developed by the American Academy of Pediatrics' (AAP) Committee on Infectious Diseases and that of the Centers for Disease Control Advisory Committee on Immunization Practices (ACIP).

Sign in / Sign up

Export Citation Format

Share Document